Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applications

R Huang, X Zhou, G Chen, L Su, Z Liu… - Wiley …, 2022 - Wiley Online Library
Functional nanomaterials have been widely used in biomedical fields due to their good
biocompatibility, excellent physicochemical properties, easy surface modification, and easy …

Molecular imaging of β-cells: diabetes and beyond

W Wei, EB Ehlerding, X Lan, QY Luo, W Cai - Advanced drug delivery …, 2019 - Elsevier
Since diabetes is becoming a global epidemic, there is a great need to develop early β-cell
specific diagnostic techniques for this disorder. There are two types of diabetes (ie, type 1 …

Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer

T Yildiz, R Gu, S Zauscher… - International journal of …, 2018 - Taylor & Francis
Introduction Despite significant progress in the field of oncology, cancer remains one of the
leading causes of death. Chemotherapy is one of the most common treatment options for …

Theranostic applications of lutetium-177 in radionuclide therapy

T Das, S Banerjee - Current Radiopharmaceuticals, 2016 - ingentaconnect.com
Lutetium-177 has been widely discussed as a radioisotope of choice for targeted
radionuclide therapy. The simultaneous emission of imageable gamma photons [208 keV …

[HTML][HTML] Indocyanine green-loaded perfluorocarbon nanoemulsions for bimodal 19F-magnetic resonance/nearinfrared fluorescence imaging and subsequent …

YG Wang, H Kim, S Mun, D Kim… - Quantitative imaging in …, 2013 - ncbi.nlm.nih.gov
We have developed an indocyanine green-loaded perfluorocarbon (ICG/PFCE)
nanoemulsion as a multifunctional theranostic nanomedicine which enables not only 19 F …

A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine

H Hayat, A Nukala, A Nyamira, J Fan… - Biomedical …, 2021 - iopscience.iop.org
Nanomedicine has recently experienced unprecedented growth and development.
However, the complexity of operations at the nanoscale introduces a layer of difficulty in the …

Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting

J Yang, LJ Zhang, F Wang, T Hong, Z Liu - Advanced Drug Delivery …, 2019 - Elsevier
Diabetes is a chronic non-communicable disease affecting over 400 million people
worldwide. Diabetic patients are at a high risk of various complications, such as …

Tolerogenic iron oxide nanoparticles in type 1 diabetes: biodistribution and pharmacokinetics studies in nonobese diabetic mice

C Dubreil, O Sainte Catherine, Y Lalatonne, C Journé… - Small, 2018 - Wiley Online Library
Nanoparticle (NP) administration is among the most attractive approaches to exploit the
synergy of different copackaged molecules for the same target. In this work, iron oxide NPs …

Occupational and ambient radiation exposures from Lu-177 DOTATATE during targeted therapy

A Sulieman, FH Mayhoub, H Salah… - Applied Radiation and …, 2020 - Elsevier
Abstract Lutetium-177 (DOTATATE)(177 Lu; T 1/2 6.7 days), a labelled β− and Auger-
electron emitter, is widely used in treatment of neuroendocrine tumours. During performance …

Targeted delivery of harmine to xenografted human pancreatic islets promotes robust cell proliferation

S Mishra, PR Streeter - Scientific Reports, 2022 - nature.com
Abstract Type 1 diabetes (T1D) occurs as a consequence of the autoimmune destruction of
insulin-producing pancreatic beta (β) cells and commonly presents with insulin deficiency …